Dr. Bandyopadhyay is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
15 Whalen Court
West Orange, NJ 07052Phone+1 908-372-8960
Education & Training
- Case Western Reserve UniversityMS, Biomedical Engineering, 2021 - 2024
- McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 2004 - 2006
- University of Chicago (NorthShore)Residency, Internal Medicine, 2004 - 2006
- McGaw Medical Center of Northwestern UniversityInternship, Internal Medicine, 2001 - 2002
- University of Chicago (NorthShore)Internship, Transitional Year, 2001 - 2002
- University of Illinois College of MedicineClass of 2001
- University of Illinois at Urbana-ChampaignBS, Electrical Engineering - Bioengineering, With Highest Honors, 1991 - 1995
- University of Illinois at Urbana-ChampaignBS, School of Life Sciences - Physiology, Magna Cum Laude, 1991 - 1995
Certifications & Licensure
- NJ State Medical License 2016 - 2025
- MI State Medical License 2009 - 2019
- NY State Medical License 2007 - 2018
- PA State Medical License 2016 - 2018
- IL State Medical License 2004 - 2006
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Certificate of Recognition: Innovator Award DM Clinical Research, 2023
- "Bravo" Award for Service Excellence Oakwood Hospital and Medical Center, 2012
- Electrical Engineering Honor Society Eta Kappa Nu, 1993-1995
- Join now to see all
Clinical Trials
- Safety and Efficacy Study of Tesofensine/Metoprolol Treatment in Subjects With Type 2 Diabetes Mellitus Start of enrollment: 2016 Apr 01
- Evaluation of Long Term Safety of Tesofensine in Patients With Obesity Start of enrollment: 2007 May 01
Publications & Presentations
PubMed
- Modelling science return from the lunar crater radio telescope on the far side of the moon.Dario Pisanti, Ashish Goel, Gaurangi Gupta, Manan Arya, Benjamin Byron
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences. 2024-05-09 - 3 citationsClinical outcomes of post-renal transplant patients with COVID-19 infection in the ICU: A single-center case seriesNissar Shaikh, Mohamad Y. Khatib, Mohammad A. Alwraidat, Dore C. Ananthegowda, Muftah Othman
Clinical Case Reports. 2021-07-01
Journal Articles
- Ultrasound hyperthermia system for breast cancer treatment.Burdette EC, Bandyopadhyay S, Proceedings of the IEEE Ultrasonics Symposium
- Spatio-Temporal Modelling and Adaptive Acquisition for Cardiac MRI.Aggarwal N, Bandyopadhyay S, and Y Bresler, Proceedings of the International Symposium on Biomedical Imaging
Books/Book Chapters
Research History
- InvestigatorNova 301: Phase III trial of mRNA 1403-P301 vaccine against Norovirus (Moderna).2024 - 2026
- InvestigatorPhase II Trial of JCXH-105-021, RNA vaccine to prevent Shingles, compared to licensed Herpes Zoster Vaccine (Immorna Therapeutics).2022 - 2026
- InvestigatorFluent: a Phase III trial of mRNA 1010-P301 for prevention of influenza (Moderna).2024 - 2025
- Director, Clinical AffairsEarly Feasibility Study of J-Valve in High- & Intermediate-Risk Aortic Regurgitation (JC Medical).2022 - 2022
- Medical Liaisonevoke/evoke+ trials, Phase III Clinical Trial to confirm the effect of oral GLP-1 receptor agonist Semaglutide for the treatment of mild cognitive impairment or mild dementia of Alzheimer’s Type (Novo Nordisk A/S).2022 - 2022
- Protocol and Imaging Charter Committee MemberPhase III Trial of a Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Study of Surrogate Endpoints for Cardiovascular Risks with Treatment of Tesofensine versus Sibutramine in Overweight or Obese Subjects with Hypertension (NeuroSearch A/S).2008 - 2010
- Protocol Committee Member, ANDA SubmissionPhase I Study to establish the bio-availability of controlled-release Naproxen granules compared to twice-a-day Naprosyn in adult patients (STI Pharma, LLC).2007 - 2009
- Protocol Committee Member, NDA SubmissionPhase I/II Clinical Trial of the efficacy and safety of the PPAR-gamma partial agonist Balaglitazone in renal disease (Rheoscience AS).2007 - 2008
- Co-InvestigatorPhase I/II Clinical Trial of "Eagle-Heart", a novel, manganese-based cardiac MRI contrast agent (Bracco Diagnostics and ImaRx Pharmaceuticals).2004 - 2006
Other Languages
- Bengali, French, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: